Research Directory

Unlocking value in pharma R&D

Read more

UK biotech, fixing a broken dream

Read more

Small company, big theme: How iOnctura is pursuing drug resistance

Read more

Raising the threshold: argenx predicts continued market expansion

Read more

GLP-1 agonist shortages set to continue

Read more

Efpia: A competitive strategy for the future

Read more

Europe's capital markets continue to struggle

Read more

Provincialism holds back Europe's biotech sector

Read more

Changes in the landscape for genome editing

Read more

Enterome: A microbiome approach to cancer therapy

Read more